Skip to main content

Publisher: Elsevier

Volume 5, Number 17, 7 September 1995

Diastereoselective synthesis of mixanpril, an orally active dual inhibitor of neutral endopeptidase and angiotensin converting enzyme.
pp. 1893-1898(6)
Authors: Turcaud, S.; Gonzalez, W.; Michel, J.; Roques, B.P.; Fournie-Zaluski, M.

Favourites:
ADD
Favourites:
ADD

A new class of angiotensin II receptor antagonists with a novel acidic bioisostere
pp. 1903-1908(6)
Authors: Kohara, Y.; Imamiya, E.; Kubo, K.; Wada, T.; Inada, Y.; Naka, T.

Favourites:
ADD

Novel open-ring analogues of N5,N10-methylenetetrahydrofolic acid with selective activity against brain tumor
pp. 1909-1912(4)
Authors: Hui-po, W.; Tung-shing, B.; On, L.; Kai-der, K.

Favourites:
ADD

Silver selective tridentate thioether coronands
pp. 1917-1918(2)
Authors: Kumar, S.; Bhalla, V.; Singh, H.

Favourites:
ADD

Synthesis and biological evaluation of 14-alkoxymorphinans. 12.1 A phenethyl analogue of the -selective opioid receptor antagonist cyprodime
pp. 1923-1926(4)
Authors: Schmidhammer, H.; Stangl, A.; Furst, Z.; Szabo, E.; Borsodi, A.; Patel, D.; Traynor, J.R.

Favourites:
ADD

Hydroxy-anthraquinones as antimalarial agents
pp. 1927-1932(6)
Authors: Winter, R.W.; Cornell, K.A.; Johnson, L.L.; Isabelle, L.M.; Hinrichs, D.J.; Riscoe, M.K.

Favourites:
ADD

A Water Soluble Benzazepine Cholecystokinin-B Receptor Antagonist
pp. 1933-1936(4)
Authors: Lowe, J.A.; Drozda, S.E.; McLean, S.; Bryce, D.K.; Crawford, R.T.; Zorn, S.; Morrone, J.; Appleton, T.A.; Lombardo, F.

Favourites:
ADD

Design, synthesis and sar of RGD peptide hybrids as highly efficient inhibitors of platelet aggregation
pp. 1941-1946(6)
Authors: Ojima, I.; Dong, Q.; Chakravarty, S.; Peerschke, E.; Shing, M.H.; Angela, S.W.

Favourites:
ADD

Estimating Ki values for tight binding inhibitors from dose-response plots
pp. 1947-1952(6)
Authors: Copeland, R.A.; Lombardo, D.; Giannaras, J.; Decicco, C.P.

Favourites:
ADD
Favourites:
ADD

Purine 2',3'-acyclonucleosides: improved synthesis and antiparasitic activity
pp. 1961-1964(4)
Authors: Sufrin, J.R.; Spiess, A.J.; Marasco, C.J.; Croft, S.L.; Snowdon, D.; Yardley, V.; Bacchi, C.J.

Favourites:
ADD

Discovery of Micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles.
pp. 1965-1968(4)
Authors: Masamune, H.; Cheng, J.B.; Cooper, K.; Eggler, J.F.; Marfat, A.; Marshall, S.C.; Shirley, J.T.; Tickner, J.E.; Umland, J.P.; Vazquez, E.

Favourites:
ADD

Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated affinity for the [3H]rolipram binding site.
pp. 1969-1972(4)
Authors: Cheng, J.B.; Cooper, K.; Duplantier, A.J.; Eggler, J.F.; Kraus, K.G.; Marshall, S.C.; Marfat, A.; Masamune, H.; Shirley, J.T.; Tickner, J.E.; Umland, J.P.

Favourites:
ADD

Phosphodiesterase Type IV (PDE IV) Inhibition. Synthesis and Evaluation of a Series of 1, 3, 4-Trisubstituted Pyrrolidines
pp. 1977-1982(6)
Authors: Stafford, J.A.; Valvano, N.L.; Feldman, P.L.; Brawley, E.S.; Cowan, D.J.; Domanico, P.L.; Leesnitzer, M.A.; Rose, D.A.; Stimpson, S.A.; Strickland, A.B.; Unwalla, R.J.; Verghese, M.W.

Favourites:
ADD

Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants
pp. 1983-1988(6)
Authors: Itoh, S.; DeCenzo, M.T.; Livingston, D.J.; Pearlman, D.A.; Navia, M.A.

Favourites:
ADD

Synthesis and Biological Activity of J-104,118, A Novel, Potent Inhibitor of Squalene Synthase
pp. 1989-1994(6)
Authors: Iwasawa, Y.; Hayashi, M.; Nomoto, T.; Shibata, J.; Mitsuya, M.; Hirota, K.; Yonemoto, M.; Kamei, T.; Miura, K.; Tomimoto, K.

Favourites:
ADD

2-alkyl-4-ethyl-5-[6-methyl-6-(2H-tetrazol-5-yl)heptyloxy]phenol leukotriene B4 receptor antagonists
pp. 1995-2000(6)
Authors: Sofia, M.J.; Nelson, K.; Herron, D.K.; Goodson, T.; Froelich, L.L.; Spaethe, S.M.; Marder, P.; Roman, C.R.; Fleisch, J.H.

Favourites:
ADD

Novel inhibitors of cholesteryl ester transfer protein
pp. 2005-2010(6)
Authors: Chackalamannil, S.; Yan, X.; Yuguang, W.; Hsingan, T.; Czarniecki, M.; Suke, W.; Clemmons, A.; Ho-Sam, A.; Boykow, G.

Favourites:
ADD

Dioxolane cytosine nucleosides as anti-hepatitis B agents
pp. 2011-2014(4)
Authors: Migyoung, L.; Chung, K.C.; Pai, S.B.; Yong-Lian, Z.; Yung-Chi, C.; Moon, W.C.; Won, K.C.

Favourites:
ADD

Novel PKC inhibitory analogs of balanol with replacement of the ester functionality
pp. 2015-2020(6)
Authors: Jagdmann, G.E.; Defauw, J.M.; Yen-Shi, L.; Crane, H.M.; Hall, S.E.; Buben, J.A.; Hong, H.; Gosnell, P.A.

Favourites:
ADD

Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease
pp. 2021-2026(6)
Authors: Kaldor, S.W.; Hammond, M.; Dressman, B.A.; Labus, J.M.; Chadwell, F.W.; Kline, A.D.; Heinz, B.A.

Favourites:
ADD

Isolation and structure of the exceptional pterobranchia human cancer inhibitors cephalostatins 16 and 17
pp. 2027-2032(6)
Authors: Pettit, G.R.; Jun-Ping, X.; Schmidt, J.M.; Boyd, M.R.

Favourites:
ADD
Favourites:
ADD

A case study of combinatorial libraries: endothelin receptor antagonist hexapeptides
pp. 2041-2044(4)
Authors: Neustadt, B.; Wu, A.; Smith, E.M.; Nechuta, T.; Fawzi, A.; Zhang, H.; Ganguly, A.K.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more